Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells

Cellular and Molecular Life Sciences

Volumn 70, Issue 3, 2013, Pages 545-558

  Parrillas, Verónica ^a   Martínez Muñoz, Laura ^a   Holgado, Borja L ^a   Kumar, Amit ^a,c   Cascio, Graciela ^a   Lucas, Pilar ^a   Rodríguez Frade, José Miguel ^a   Malumbres, Marcos ^b   Carrera, Ana C ^a   Van Wely, Karel H M ^a   Mellado, Mario ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b Structural Biology and Biocomputing Programme   (Spain)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Cdh1; Cell cycle; SOCS1; Tumor suppressor

Indexed keywords

AURORA A KINASE; CELL CYCLE PROTEIN 20; CYCLIN B1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; NOCODAZOLE; PROTEASOME; PROTEIN INHIBITOR; PROTEIN P19; PROTEIN P53; SECURIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; METAPHASE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CADHERINS; CARRIER PROTEINS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN B1; CYCLIN D; CYCLIN E; HUMANS; MELANOMA; METAPHASE; MICE; MICE, NUDE; MITOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84872342167     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1145-8     Document Type: Article

References (63)

1. Karpinski P, Myszka A, Ramsey D, Kielan W, Sasiadek MM (2011) Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype. Tumour Biol 32(4):653-659. doi:10.1007/s13277-011-0165-6
2. Hua D, Hu Y, Wu YY, Cheng ZH, Yu J, Du X, Huang ZH (2011) Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma. Exp Mol Pathol 91(1):455-460. doi:10.1016/j.yexmp.2011.05.001
3. Sasi W, Jiang WG, Sharma A, Mokbel K (2010) Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer. BMC Cancer 10:178. doi:10.1186/1471-2407-10-178
4. Sutherland LC, Lerman M, Williams GT, Miller BA (2001) LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells. Oncogene 20(21):2713-2719. doi:10.1038/sj.onc.1204371
5. Hashimoto M, Ayada T, Kinjyo I, Hiwatashi K, Yoshida H, Okada Y, Kobayashi T, Yoshimura A (2009) Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation. Cancer Sci 100(4):730-736
6. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28(1):29-35. doi:10.1038/88225
7. Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, Hoon DS (2009) CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15(5):1801-1807. doi:10.1158/1078-0432.CCR-08-1361
8. Marine JC, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, Yoshimura A, Ihle JN (1999) SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98(5):609-616
9. Starr R, Metcalf D, Elefanty AG, Brysha M, Willson TA, Nicola NA, Hilton DJ, Alexander WS (1998) Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci USA 95(24):14395-14399
10. Metcalf D, Mifsud S, Di Rago L, Nicola NA, Hilton DJ, Alexander WS (2002) Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). Proc Natl Acad Sci USA 99(2):943-948. doi:10.1073/pnas.022628499
11. Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubreuil P, de Sepulveda P (2002) The tumor suppressor activity of SOCS-1. Oncogene 21(28):4351-4362. doi:10.1038/sj.onc.1205537
12. Huang JN, Park I, Ellingson E, Littlepage LE, Pellman D (2001) Activity of the APC(Cdh1) form of the anaphase-promoting complex persists until S phase and prevents the premature expression of Cdc20p. J Cell Biol 154(1):85-94
13. Flowers LO, Subramaniam PS, Johnson HM (2005) A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells. Oncogene 24(12):2114-2120. doi:10.1038/sj.onc.1208437
14. Vuong BQ, Arenzana TL, Showalter BM, Losman J, Chen XP, Mostecki J, Banks AS, Limnander A, Fernandez N, Rothman PB (2004) SOCS-1 localizes to the microtubule organizing complexassociated 20S proteasome. Mol Cell Biol 24(20):9092-9101. doi:10.1128/MCB.24.20.9092-9101.2004
15. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SB, Alexander WS, Metcalf D, Hilton DJ, Nicola NA, Baca M (1999) The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci USA 96(5):2071-2076
16. Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O (2002) Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol 22(10):3316-3326
17. Rui L, Yuan M, Frantz D, Shoelson S, White MF (2002) SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277(44):42394-42398. doi:10.1074/jbc.C200444200
18. Nihira K, Ando Y, Yamaguchi T, Kagami Y, Miki Y, Yoshida K (2010) Pim-1 controls NF-kappaB signalling by stabilizing RelA/ p65. Cell Death Differ 17(4):689-698. doi:10.1038/cdd.2009.174
19. Liu E, Cote JF, Vuori K (2003) Negative regulation of FAK signaling by SOCS proteins. EMBO J 22(19):5036-5046. doi: 10.1093/emboj/cdg503
20. Brockman JL, Schroeder MD, Schuler LA (2002) PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol Endocrinol 16(4):774-784
21. Walz C, Crowley BJ, Hudon HE, Gramlich JL, Neuberg DS, Podar K, Griffin JD, Sattler M (2006) Activated Jak2 with the V617F point mutation promotes G1/S phase transition. J Biol Chem 281(26):18177-18183. doi:10.1074/jbc.M600064200
22. Moran DM, Mattocks MA, Cahill PA, Koniaris LG, McKillop IH (2008) Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. J Surg Res 147(1):23-33. doi:10.1016/j.jss.2007.04.022
23. Narimatsu M, Nakajima K, Ichiba M, Hirano T (1997) Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest. Biochem Biophys Res Commun 238(3):764-768. doi:10.1006/bbrc.1997.7387
24. Calabrese V, Mallette FA, Deschenes-Simard X, Ramanathan S, Gagnon J, Moores A, Ilangumaran S, Ferbeyre G (2009) SOCS1 links cytokine signaling to p53 and senescence. Mol Cell 36(5):754-767. doi:10.1016/j.molcel.2009.09.044
25. Castro A, Bernis C, Vigneron S, Labbe JC, Lorca T (2005) The anaphase-promoting complex: a key factor in the regulation of cell cycle. Oncogene 24(3):314-325. doi:10.1038/sj.onc.1207973
26. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9(3):153-166. doi: 10.1038/nrc2602
27. Morgan DO (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13:261-291. doi: 10.1146/annurev. cellbio.13.1.261
28. Glotzer M, Murray AW, Kirschner MW (1991) Cyclin is degraded by the ubiquitin pathway. Nature 349(6305):132-138. doi:10.1038/349132a0
29. Hershko A, Ganoth D, Pehrson J, Palazzo RE, Cohen LH (1991) Methylated ubiquitin inhibits cyclin degradation in clam embryo extracts. J Biol Chem 266(25):16376-16379
30. Visintin R, Prinz S, Amon A (1997) CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278(5337):460-463
31. Robbins JA, Cross FR (2010) Regulated degradation of the APC coactivator Cdc20. Cell Div 5:23. doi:10.1186/1747-1028-5-23
32. Yu H (2002) Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin Cell Biol 14(6):706-714
33. Fang G, Yu H, Kirschner MW (1998) The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev 12(12):1871-1883
34. Tipton AR, Wang K, Link L, Bellizzi JJ, Huang H, Yen T, Liu ST (2011) BUBR1 and closed MAD2 (C-MAD2) interact directly to assemble a functional mitotic checkpoint complex. J Biol Chem 286(24):21173-21179. doi:10.1074/jbc.M111.238543
35. Listovsky T, Zor A, Laronne A, Brandeis M (2000) Cdk1 is essential for mammalian cyclosome/APC regulation. Exp Cell Res 255(2):184-191. doi:10.1006/excr.1999.4788
36. Hayes MJ, Kimata Y, Wattam SL, Lindon C, Mao G, Yamano H, Fry AM (2006) Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C. Nat Cell Biol 8(6):607-614. doi:10.1038/ncb1410
37. Bassermann F, Frescas D, Guardavaccaro D, Busino L, Peschiaroli A, Pagano M (2008) The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell 134(2):256-267. doi:10.1016/j.cell.2008.05.043
38. Song MS, Carracedo A, Salmena L, Song SJ, Egia A, Malumbres M, Pandolfi PP (2011) Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144(2):187-199. doi:10.1016/j.cell. 2010.12.020
39. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38(9):1043-1048. doi:10.1038/ng1861
40. Floyd S, Pines J, Lindon C (2008) APC/C Cdh1 targets aurora kinase to control reorganization of the mitotic spindle at anaphase. Curr Biol 18(21):1649-1658. doi:10.1016/j.cub. 2008.09.058
41. Treier M, Staszewski LM, Bohmann D (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78(5):787-798
42. Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortiz MC, Martinez AC, Mellado M (1999) The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. Faseb J 13(13):1699-1710
43. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5):593-602
44. Martinez Munoz L, Lucas P, Navarro G, Checa AI, Franco R, Martinez AC, Rodriguez-Frade JM, Mellado M (2009) Dynamic regulation of CXCR1 and CXCR2 homo-and heterodimers. J Immunol 183(11):7337-7346. doi:10.4049/jimmunol.0901802
45. Honda R, Yasuda H (1999) Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 18(1):22-27. doi:10.1093/emboj/18.1.22
46. Fuke H, Shiraki K, Sugimoto K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Masuya M, Takei Y (2007) Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 363(3):738-744. doi:10.1016/j.bbrc. 2007.09.049
47. Croker BA, Kiu H, Nicholson SE (2008) SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 19(4):414-422. doi:10.1016/j.semcdb. 2008.07.010
48. Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798-809. doi:10.1038/nrc2734
49. Baker DJ, Dawlaty MM, Galardy P, van Deursen JM (2007) Mitotic regulation of the anaphase-promoting complex. Cell Mol Life Sci 64(5):589-600. doi:10.1007/s00018-007-6443-1
50. Lukasiewicz KB, Greenwood TM, Negron VC, Bruzek AK, Salisbury JL, Lingle WL (2011) Control of centrin stability by aurora A. PLoS ONE 6(6):e21291. doi:10.1371/journal.pone. 0021291
51. Qiao X, Zhang L, Gamper AM, Fujita T, Wan Y (2010) APC/CCdh1: from cell cycle to cellular differentiation and genomic integrity. Cell Cycle 9(19):3904-3912
52. Kim S, Yu H (2011) Mutual regulation between the spindle checkpoint and APC/C. Semin Cell Dev Biol. doi:10.1016/j. semcdb.2011.03.008
53. Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HM, Hilton DJ (2002) The SOCS box: a tale of destruction and degradation. Trends Biochem Sci 27(5):235-241
54. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387(6636):917-921. doi:10.1038/43206
55. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387(6636):924-929. doi:10.1038/43219
56. Bharadwaj U, Li M, Chen C, Yao Q (2008) Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3. Mol Cancer Res 6(11):1755-1765. doi:10.1158/ 1541-7786.MCR-08-0095
57. Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J (2006) Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res 66(5):2544-2552. doi: 10.1158/0008-5472.CAN-05-2203
58. Quintanilla-Martinez L, Davies-Hill T, Fend F, Calzada-Wack J, Sorbara L, Campo E, Jaffe ES, Raffeld M (2003) Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. Blood 101(8):3181-3187. doi:10.1182/blood-2002-01-0263
59. Garcia-Higuera I, Manchado E, Dubus P, Canamero M, Mendez J, Moreno S, Malumbres M (2008) Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat Cell Biol 10(7):802-811. doi:10.1038/ncb1742
60. Pesin JA, Orr-Weaver TL (2008) Regulation of APC/C activators in mitosis and meiosis. Annu Rev Cell Dev Biol 24:475-499. doi: 10.1146/annurev.cellbio. 041408.115949
61. Ma Y, Yuan X, Wyatt WR, Pomerening JR (2012) Expression of constitutively active CDK1 stabilizes APC-Cdh1 substrates and potentiates premature spindle assembly and checkpoint function in G1 cells. PLoS ONE 7(3):e33835. doi:10.1371/journal. pone.0033835
62. Hames RS, Wattam SL, Yamano H, Bacchieri R, Fry AM (2001) APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box. EMBO J 20(24):7117-7127. doi:10.1093/emboj/20.24. 7117
63. Liu Q, Hirohashi Y, Du X, Greene MI, Wang Q (2010) Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancer. Exp Mol Pathol 88(2):225-233. doi:10.1016/j.yexmp.2009.12.004